![](https://i.imgur.com/CLvY2jA.png")
28-11-2021, 10:21 PM
Bloom said his experiments show initial indications that the Regeneron-Roche cocktail could “take a hit.”
“I think this shows the importance of work going on in academia and in industry to continue to find more antibodies against SARS-CoV-2 because it’s clear the reason people were doing this is we know that new variants were arising,” Bloom said. “It’s clear that’s going to continue to happen.”
https://www.washingtonpost.com/health/20...t-omicron/
There is a bigger risk that monoclonal antibodies, such as Regeneron’s treatment, could fail or partially fail because they target parts of the virus that will have mutated.
https://www.theguardian.com/world/2021/n...id-variant
“I think this shows the importance of work going on in academia and in industry to continue to find more antibodies against SARS-CoV-2 because it’s clear the reason people were doing this is we know that new variants were arising,” Bloom said. “It’s clear that’s going to continue to happen.”
https://www.washingtonpost.com/health/20...t-omicron/
There is a bigger risk that monoclonal antibodies, such as Regeneron’s treatment, could fail or partially fail because they target parts of the virus that will have mutated.
https://www.theguardian.com/world/2021/n...id-variant
